These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 10875254

  • 1. Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro.
    Masiukiewicz US, Mitnick M, Grey AB, Insogna KL.
    Endocrinology; 2000 Jul; 141(7):2526-31. PubMed ID: 10875254
    [Abstract] [Full Text] [Related]

  • 2. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W, Schot L, Ederveen A, van der Wee-Pals L, Papapoulos S, Löwik C.
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [Abstract] [Full Text] [Related]

  • 3. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V, Birchman R, Wu DD, Lindsay R.
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [Abstract] [Full Text] [Related]

  • 4. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.
    Passeri G, Girasole G, Jilka RL, Manolagas SC.
    Endocrinology; 1993 Aug; 133(2):822-8. PubMed ID: 8393776
    [Abstract] [Full Text] [Related]

  • 5. Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women.
    Masiukiewicz US, Mitnick M, Gulanski BI, Insogna KL.
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2892-8. PubMed ID: 12050269
    [Abstract] [Full Text] [Related]

  • 6. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.
    Grey A, Mitnick MA, Masiukiewicz U, Sun BH, Rudikoff S, Jilka RL, Manolagas SC, Insogna K.
    Endocrinology; 1999 Oct; 140(10):4683-90. PubMed ID: 10499526
    [Abstract] [Full Text] [Related]

  • 7. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
    Insogna K, Mitnick M, Pascarella J, Nakchbandi I, Grey A, Masiukiewicz U.
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787
    [Abstract] [Full Text] [Related]

  • 8. Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells.
    Eielson C, Kaplan D, Mitnick MA, Paliwal I, Insogna K.
    Endocrinology; 1994 Oct; 135(4):1639-44. PubMed ID: 7925127
    [Abstract] [Full Text] [Related]

  • 9. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
    Vargas SJ, Naprta A, Lee SK, Kalinowski J, Kawaguchi H, Pilbeam CC, Raisz LG, Lorenzo JA.
    J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
    [Abstract] [Full Text] [Related]

  • 10. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H, Shen V, Dempster DW, Lindsay R.
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [Abstract] [Full Text] [Related]

  • 11. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone increases circulating levels of fibronectin in vivo: modulating effect of ovariectomy.
    Sun BH, Mitnick M, Eielson C, Yao GQ, Paliwal I, Insogna K.
    Endocrinology; 1997 Sep; 138(9):3918-24. PubMed ID: 9275082
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ, Yen CF, Qi H, Dann LM.
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [Abstract] [Full Text] [Related]

  • 14. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L.
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R.
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [Abstract] [Full Text] [Related]

  • 16. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
    Turner RT, Evans GL, Cavolina JM, Halloran B, Morey-Holton E.
    Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
    [Abstract] [Full Text] [Related]

  • 17. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J, Miller MA, Newman MK, Turner CH, Recker RR, Smith SY.
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y, Won YY, Baek MH, Lim SK.
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [Abstract] [Full Text] [Related]

  • 19. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR.
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [Abstract] [Full Text] [Related]

  • 20. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
    Chikazu D, Shindo M, Iwasaka T, Katagiri M, Manabe N, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.